Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,903,706
-
Number of holders
-
151
-
Total 13F shares, excl. options
-
26,536,136
-
Shares change
-
+760,556
-
Total reported value, excl. options
-
$541,803,165
-
Value change
-
+$16,367,707
-
Number of buys
-
83
-
Number of sells
-
-88
-
Price
-
$20.42
Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q2 2025
196 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q2 2025.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,536,136 shares
of 28,903,706 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (3,154,679 shares), VANGUARD GROUP INC (2,170,028 shares), PRINCIPAL FINANCIAL GROUP INC (1,798,974 shares), Portolan Capital Management, LLC (1,489,572 shares), DIMENSIONAL FUND ADVISORS LP (1,378,005 shares), Nuveen, LLC (1,073,107 shares), WASATCH ADVISORS LP (1,049,773 shares), CITADEL ADVISORS LLC (888,515 shares), BRAIDWELL LP (822,735 shares), and Allianz Asset Management GmbH (713,742 shares).
This table shows the top 151 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.